<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01301274</url>
  </required_header>
  <id_info>
    <org_study_id>HGNPE-20-2011</org_study_id>
    <nct_id>NCT01301274</nct_id>
  </id_info>
  <brief_title>0.9% NaCl/Dextrose 5% vs 0.45% NaCl/Dextrose 5% as Maintenance Intravenous Fluids in Critically Ill Children</brief_title>
  <acronym>NaCrICh</acronym>
  <official_title>Randomized, Controlled, Double Blinded, Clinical Trial: 0.9% NaCl/Dextrose 5% vs 0.45% NaCl/Dextrose 5% as Maintenance Intravenous Fluids in Critically Ill Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital General de Niños Pedro de Elizalde</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital General de Niños Pedro de Elizalde</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to compare the mean serum sodium after 48 hours of
      therapy with either 0.45% NaCl/dextrose 5% or 0.9% NaCl/dextrose 5%, in critically ill
      children requiring IV maintenance fluid administration.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In patients without possibilities of oral intake, maintenance fluids provide electrolytes and
      water. Since the original descriptions by Holliday and Segar, the recommended standard
      maintenance solutions are based on &quot;physiological needs&quot;, containing 30-50 mEq/L of sodium.

      However hyponatremia has become increasingly recognized in hospitalized children suggesting
      that Holliday and Segar's recommendations are frequently inappropriately applied.

      It has been described augmented intersticial lung water in patients receiving hypotonic
      maintenance solutions. Also, hyponatremia has been demonstrated in post-surgery critically
      ill children receiving hypotonic maintenance solutions.

      More over, non-physiologic antidiuretic hormone (ADH) secretion has been described in the
      great majority of hospitalized children due to nausea, stress, pain, and/or surgical
      interventions.

      It has been suggested that isotonic 0.9% NaCl/dextrose 5% should be the standard maintenance
      intravenous (IV) solution, to avoid the development of hyponatremia.

      There are not studies in critically ill children evaluating the effect of isotonic solutions
      on sodium levels.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2011</start_date>
  <completion_date type="Actual">November 2011</completion_date>
  <primary_completion_date type="Actual">November 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serum Sodium Levels in Both Groups</measure>
    <time_frame>first 48 hours</time_frame>
    <description>Mean serum sodium level of each group will be compared at baseline and in the first 48 hours of IV fluid infusion</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality at 28 Days</measure>
    <time_frame>28 days after admission</time_frame>
    <description>Mortality in both groups will be compared 28 days after admission</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mechanical Ventilation Free Days at 28 Day of Admission</measure>
    <time_frame>first 28 day after starting mechanical ventilation</time_frame>
    <description>mechanical ventilation free days at the first 28 day of starting mechanical ventilation, if the patient died the corresponding value is zero.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU Length of Stay</measure>
    <time_frame>180 days</time_frame>
    <description>ICU length of stay (in days)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">66</enrollment>
  <condition>Hyponatremia</condition>
  <arm_group>
    <arm_group_label>Hypotonic</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects in this arm will receive 0.45% NaCl/5% dextrose intravenous maintenance fluids.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Isotonic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects in this arm will receive 0.9% NaCl/5% dextrose intravenous maintenance fluids.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>hypotonic</intervention_name>
    <description>0.45% NaCl/5% dextrose IV maintenance fluids</description>
    <arm_group_label>Hypotonic</arm_group_label>
    <other_name>half saline/5% dextrose</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>isotonic</intervention_name>
    <description>0.9% NaCl/5% dextrose IV maintenance fluids</description>
    <arm_group_label>Isotonic</arm_group_label>
    <other_name>normal saline/5% dextrose</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 1 month to 18 years

          -  ICU stay &gt;24 hours

          -  Normal seric sodium (135 - 145 mEq/L).

          -  Requirement of IV maintenance solutions &gt;80% total fluids intake

        Exclusion Criteria:

          -  Patients with diagnoses of renal failure (serum creatinine &gt;1 g/dl in &lt;3 years old
             children, &gt;1,5 in &gt;3 years), hepatic failure with ascitis and portal hypertension,
             adrenal failure, nephrotic - nephritic syndrome, Kawasaki disease, sickle cell anemia,
             Syndrome of inappropriate antidiuretic hormone secretion, diabetes insipidus,metabolic
             disease.

          -  Diuretics use in the first 48 hours thereafter indicated IV solutions.

          -  Plasma glucose is &gt;200 mg%.

          -  Any patients requiring IV fluids therapy different that maintenance (total parenteral
             nutrition, hyperhydration).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Facundo A Jorro, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital General de Niños Pedro de Elizalde</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gustavo De Baisi, MD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital General de Niños Pedro de Elizalde</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Susana Bengoa</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital General de Niños Pedro de Elizalde</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital General de Niños Pedro de Elizalde</name>
      <address>
        <city>Buenos Aires</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Argentina</country>
  </location_countries>
  <reference>
    <citation>HOLLIDAY MA, SEGAR WE, LUKENBILL A, VALENCIA RM, DURELL AM. Variations in muscle electrolyte composition due to sampling and to aging. Proc Soc Exp Biol Med. 1957 Aug-Sep;95(4):786-8.</citation>
    <PMID>13465804</PMID>
  </reference>
  <reference>
    <citation>Burrows FA, Shutack JG, Crone RK. Inappropriate secretion of antidiuretic hormone in a postsurgical pediatric population. Crit Care Med. 1983 Jul;11(7):527-31.</citation>
    <PMID>6861500</PMID>
  </reference>
  <reference>
    <citation>Eulmesekian PG, Pérez A, Minces PG, Bohn D. Hospital-acquired hyponatremia in postoperative pediatric patients: prospective observational study. Pediatr Crit Care Med. 2010 Jul;11(4):479-83. doi: 10.1097/PCC.0b013e3181ce7154.</citation>
    <PMID>20124948</PMID>
  </reference>
  <reference>
    <citation>Choong K, Kho ME, Menon K, Bohn D. Hypotonic versus isotonic saline in hospitalised children: a systematic review. Arch Dis Child. 2006 Oct;91(10):828-35. Epub 2006 Jun 5. Review.</citation>
    <PMID>16754657</PMID>
  </reference>
  <verification_date>March 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 18, 2011</study_first_submitted>
  <study_first_submitted_qc>February 18, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 23, 2011</study_first_posted>
  <results_first_submitted>November 16, 2011</results_first_submitted>
  <results_first_submitted_qc>March 6, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">March 7, 2012</results_first_posted>
  <last_update_submitted>March 6, 2012</last_update_submitted>
  <last_update_submitted_qc>March 6, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 7, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hyponatremia</keyword>
  <keyword>maintenance solutions</keyword>
  <keyword>pediatrics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
    <mesh_term>Hyponatremia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Intensive Care Unit without cardiovascular patients, since 01/02/2011 until 01/11/2011</recruitment_details>
      <pre_assignment_details>251 admitted patients to ICU, 97 eligible patients, 9 patients did not give consent, 22 were not randomized by treatment physician</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Hypotonic</title>
          <description>Subjects in this arm will receive 0.45% NaCl/5% dextrose intravenous maintenance fluids.</description>
        </group>
        <group group_id="P2">
          <title>Isotonic</title>
          <description>Subjects in this arm will receive 0.9% NaCl/5% dextrose intravenous maintenance fluids.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
                <participants group_id="P2" count="32"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="32"/>
                <participants group_id="P2" count="31"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Hypotonic</title>
          <description>Subjects in this arm will receive 0.45% NaCl/5% dextrose intravenous maintenance fluids.</description>
        </group>
        <group group_id="B2">
          <title>Isotonic</title>
          <description>Subjects in this arm will receive 0.9% NaCl/5% dextrose intravenous maintenance fluids.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="34"/>
            <count group_id="B2" value="32"/>
            <count group_id="B3" value="66"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                    <measurement group_id="B2" value="32"/>
                    <measurement group_id="B3" value="66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3" spread="4.7"/>
                    <measurement group_id="B2" value="1.2" spread="3.2"/>
                    <measurement group_id="B3" value="2.2" spread="4.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Argentina</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                    <measurement group_id="B2" value="32"/>
                    <measurement group_id="B3" value="66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Serum Sodium Levels in Both Groups</title>
        <description>Mean serum sodium level of each group will be compared at baseline and in the first 48 hours of IV fluid infusion</description>
        <time_frame>first 48 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Hypotonic Arm</title>
            <description>patients who received for maintenance solution 0.45% ClNa in Dx 5%</description>
          </group>
          <group group_id="O2">
            <title>Isotonic Arm</title>
            <description>Patients who received for maintenance solution 0.9% ClNa in Dx 5%</description>
          </group>
        </group_list>
        <measure>
          <title>Serum Sodium Levels in Both Groups</title>
          <description>Mean serum sodium level of each group will be compared at baseline and in the first 48 hours of IV fluid infusion</description>
          <units>mEq/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="137.8" spread="4.3"/>
                    <measurement group_id="O2" value="140.0" spread="4.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>beta error 20%, alfa error 5%, diminished 2 mEq/L between groups</non_inferiority_desc>
            <p_value>0.04</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mortality at 28 Days</title>
        <description>Mortality in both groups will be compared 28 days after admission</description>
        <time_frame>28 days after admission</time_frame>
        <population>The analysis was per intention to treat</population>
        <group_list>
          <group group_id="O1">
            <title>Hypotonic Arm</title>
            <description>patients who received maintenance solution 0.45% ClNa in Dx 5%</description>
          </group>
          <group group_id="O2">
            <title>Isotonic Arm</title>
            <description>patients who received maintenance solution 0.9% ClNa in Dx 5%</description>
          </group>
        </group_list>
        <measure>
          <title>Mortality at 28 Days</title>
          <description>Mortality in both groups will be compared 28 days after admission</description>
          <population>The analysis was per intention to treat</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.081</p_value>
            <p_value_desc>without adjust</p_value_desc>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mechanical Ventilation Free Days at 28 Day of Admission</title>
        <description>mechanical ventilation free days at the first 28 day of starting mechanical ventilation, if the patient died the corresponding value is zero.</description>
        <time_frame>first 28 day after starting mechanical ventilation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Hypotonic Arm</title>
            <description>patients who received fro maintenance solution ClNa 0.45% in Dx 5%</description>
          </group>
          <group group_id="O2">
            <title>Isotonic Arm</title>
            <description>patients who received for maintenance solution ClNa 0.9% in Dx 5%</description>
          </group>
        </group_list>
        <measure>
          <title>Mechanical Ventilation Free Days at 28 Day of Admission</title>
          <description>mechanical ventilation free days at the first 28 day of starting mechanical ventilation, if the patient died the corresponding value is zero.</description>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.9" spread="7.9"/>
                    <measurement group_id="O2" value="21.5" spread="6.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.396</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>ICU Length of Stay</title>
        <description>ICU length of stay (in days)</description>
        <time_frame>180 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Hypotonic Arm</title>
            <description>patients who received for maintenance solution ClNa 0.9% in Dx 5%</description>
          </group>
          <group group_id="O2">
            <title>Isotonic Arm</title>
            <description>patients who received for maintenance solution ClNa 0.9% in Dx 5%</description>
          </group>
        </group_list>
        <measure>
          <title>ICU Length of Stay</title>
          <description>ICU length of stay (in days)</description>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.5" spread="5.5"/>
                    <measurement group_id="O2" value="11.9" spread="11.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.129</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>until they were receiving the maintenance solution, mean time 24 hours up to 48 hours. The adverse events were collected up to PICU discharged, mean time 7.4 days, except mortality up to 28 days.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Hypotonic</title>
          <description>Subjects in this arm will receive 0.45% NaCl/5% dextrose intravenous maintenance fluids.</description>
        </group>
        <group group_id="E2">
          <title>Isotonic</title>
          <description>Subjects in this arm will receive 0.9% NaCl/5% dextrose intravenous maintenance fluids.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>Severe hyponatremia</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="34"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>hyponatremia &lt;130 mEq/l</sub_title>
                <description>serum sodium &lt;130 mEq/l, without symptoms.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="34"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>patient death that occurred between up to 28 days after randomization.</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="34"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>Hyponatremia</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="34"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Serum sodium &lt; 135 mEq/l</sub_title>
                <description>serum sodium between 130 - 134,9 mEq/l, without neurological symptoms.</description>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="34"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Limitations: Antidiuretic hormone were not measured.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr Facundo Jorro Barón</name_or_title>
      <organization>Intensive Care Unit - Hospital Pedro de Elizalde</organization>
      <phone>00541143632100 ext 2035</phone>
      <email>jorrobox@yahoo.com.ar</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

